Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2017-05-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-161146PMID 28505968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain Morphometry

  2018cited by this paper
• Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease

  2016cited by this paper
• Regional brain shrinkage and change in cognitive performance over two years: The bidirectional influences of the brain and cognitive reserve factors

  2016cited by this paper
• Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers.

  2016cited by this paper
• Use of amyloid-PET to determine cutpoints for CSF markers

  2016cited by this paper
• Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease

  2016cited by this paper
• The age-related neuroinflammatory environment promotes macrophage activation, which negatively impacts synaptic function.

  2016cited by this paper
• CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD.

  2016cited by this paper
• Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.

  2016cited by this paper
• CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

  2016cited by this paper
• Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.

  2015cited by this paper
• Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

  2015cited by this paper
• Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study

  2015cited by this paper
• Neuroinflammation in Alzheimer's disease.

  2015cited by this paper
• Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease

  2015cited by this paper
• Amyloid biomarkers in Alzheimer's disease.

  2015cited by this paper
• Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease

  2014cited by this paper
• What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.

  2014cited by this paper
• Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

  2014cited by this paper
• Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.

  2014cited by this paper
• The Relevance of Beta-Amyloid on Markers of Alzheimer’s Disease in Clinically Normal Individuals and Factors That Influence These Associations

  2014cited by this paper
• Brain Changes in Older Adults at Very Low Risk for Alzheimer's Disease

  2013cited by this paper
• White Matter Lesion Assessment in Patients with Cognitive Impairment and Healthy Controls: Reliability Comparisons between Visual Rating, a Manual, and an Automatic Volumetrical MRI Method—The Gothenburg MCI Study

  2013cited by this paper
• Brain morphometry reproducibility in multi-center 3 T MRI studies: A comparison of cross-sectional and longitudinal segmentations

  2013cited by this paper
• Meta-analysis of amyloid-cognition relations in cognitively normal older adults

  2013cited by this paper
• Cognitive Reserve Proxies Relate to Gray Matter Loss in Cognitively Healthy Elderly with Abnormal Cerebrospinal Fluid Amyloid-β Levels

  2013cited by this paper
• Within-subject template estimation for unbiased longitudinal image analysis

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas.

  2011cited by this paper
• Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly

  2011cited by this paper
• Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility

  2011cited by this paper
• Correlations between MRI white matter lesion location and executive function and episodic memory

  2011cited by this paper
• Avoiding asymmetry-induced bias in longitudinal image processing

  2011cited by this paper
• Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.

  2010cited by this paper
• Larger temporal volume in elderly with high versus low beta-amyloid deposition.

  2010cited by this paper
• Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

  2010cited by this paper
• Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42

  2010cited by this paper
• YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.

  2010cited by this paper
• REGIONAL BRAIN CORTICAL THINNING AND SYSTEMIC INFLAMMATION IN OLDER PERSONS WITHOUT DEMENTIA

  2010cited by this paper
• Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

  2010cited by this paper
• Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

  2010cited by this paper
• Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderly

  2009cited by this paper
• Reduced resting-state brain activity in the "default network" in normal aging.

  2008cited by this paper
• Journal of Neuroinflammation Neuro-inflammation Induced by Lipopolysaccharide Causes Cognitive Impairment through Enhancement of Beta-amyloid Generation

  2008cited by this paper
• アルツハイマー病の早期診断に向けて-米国 Alzheimer's Disease Neuroimaging Initiative の取り組み

  2006cited by this paper
• Predictors of preclinical Alzheimer's disease

  2006cited by this paper
• Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data

  2006cited by this paper
• Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.

  2005cited by this paper
• Shrinkage of the Entorhinal Cortex over Five Years Predicts Memory Performance in Healthy Adults

  2004cited by this paper
• Neurotechnique Whole Brain Segmentation: Automated Labeling of Neuroanatomical Structures in the Human Brain

  2002cited by this paper
• Clock‐drawing: is it the ideal cognitive screening test?

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Cortical surface-based analysis. I. Segmentation and surface reconstruction.

  1999cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary

  1993cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease

  1989cited by this paper
• The Revised Kendrick Battery: clinical studies.

  1979cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• The relation of the trail making test to organic brain damage.

  1955cited by this paper

• The Journey of the Default Mode Network: Development, Function, and Impact on Mental Health

  2025cites this paper
• Impacto de la composición corporal y del estado psicológico en las funciones ejecutivas de personas con obesidad

  2025cites this paper
• Plasma proteomic biomarkers as mediators or moderators for the association between poor cardiovascular health and white matter microstructural integrity: The UK Biobank study

  2025cites this paper
• Accelerated biological brain aging in major depressive disorder

  2024cites this paper
• Increases in regional brain volume across two native South American male populations

  2024cites this paper
• Diurnal cortisol, neuroinflammation, and neuroimaging visual rating scales in memory clinic patients.

  2024cites this paper
• Three-Dimensional Amyloid-Beta PET Synthesis from Structural MRI with Conditional Generative Adversarial Networks

  2024cites this paper
• Bariatric Surgery Improves Cognition Function in the Patients with Obesity: A Meta-Analysis

  2024cites this paper
• Journal Pre-proofs Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness

  2023cites this paper
• Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus

  2023cites this paper
• Seeing beyond the symptoms: biomarkers and brain regions linked to cognitive decline in Alzheimer’s disease

  2023cites this paper
• Relationships between diabetes-related vascular risk factors and neurodegeneration biomarkers in healthy aging and Alzheimer's disease.

  2022cites this paper
• Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness

  2022cites this paper
• Multisystem physiological perspective of human frailty and its modulation by physical activity

  2022cites this paper
• Generalizing Longitudinal Age Effects on Brain Structure – A Two-Study Comparison Approach

  2021cites this paper
• Adulthood systemic inflammation accelerates the trajectory of age-related cognitive decline

  2021cites this paper
• Exercise-Mediated Autophagy and Brain Aging

  2021cites this paper
• The indigenous South American Tsimane exhibit relatively modest decrease in brain volume with age despite high systemic inflammation.

  2021cites this paper
• Specific and general relationships between cortical thickness and cognition in older adults: a longitudinal study.

  2020cites this paper
• Reduced Cerebrovascular and Cardioventilatory Responses to Intermittent Hypoxia in Elderly.

  2020cites this paper
• Lactoferrin improves cognitive function and attenuates brain senescence in aged mice

  2020cites this paper
• Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults.

  2020cites this paper
• Mammary tumors suppress aging-induced neuroinflammation in female Balb/c mice

  2020cites this paper
• Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions

  2020cites this paper
• Association Between Leptin, Cognition, and Structural Brain Measures Among “Early” Middle-Aged Adults: Results from the Framingham Heart Study Third Generation Cohort

  2020cites this paper
• Cross-sectional associations of amyloid burden with semantic cognition in older adults without dementia: A systematic review and meta-analysis

  2020cites this paper
• Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults

  2019cites this paper
• Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

  2019cites this paper
• Brain aging and psychometric intelligence: a longitudinal study

  2019cites this paper
• Brain structure and cognitive ability in healthy aging: a review on longitudinal correlated change

  2019cites this paper
• CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals

  2019cites this paper
• History and progress of hypotheses and clinical trials for Alzheimer’s disease

  2019cites this paper
• From Bereavement to Grief to Cognitive Decline: A Call for Novel Treatment and Prevention Approaches.

  2018cites this paper
• Cortical microstructural changes along the Alzheimer's disease continuum

  2018cites this paper
• Neuroinflammation in Preclinical Alzheimer's Disease: A Review of Current Evidence

  2018cites this paper
• The Effect of Propofol vs. Isoflurane Anesthesia on Postoperative Changes in Cerebrospinal Fluid Cytokine Levels: Results from a Randomized Trial

  2017cites this paper
• A Biphasic model for cortical structural changes in preclinical AD: a multimodal MRI, CSF and PET study /

  2017cites this paper